Anoctamin 4 (ANO4, also known as TMEM16D) is a member of the anoctamin family of calcium-activated chloride channels (CaCCs) and phospholipid scramblases. The ANO4 gene encodes a membrane protein that functions as a calcium-dependent chloride channel with broad expression in the brain and various endocrine tissues. ANO4 is increasingly recognized for its role in neuronal excitability, synaptic transmission, and potential implications in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD).
| Property |
Value |
| Symbol |
ANO4 |
| Full Name |
Anoctamin 4 |
| Alias |
TMEM16D, ANO 4 |
| Chromosome |
12p11.23 |
| GenBank ID |
NM_001256789 |
| Protein Class |
Ion Channel (CaCC), Phospholipid Scramblase |
| Molecular Weight |
~100 kDa |
| Transmembrane Domains |
8 |
¶ Protein Structure and Function
ANO4 is a member of the TMEM16/anoctamin family, which comprises 10 members (ANO1-ANO10) in mammals. Unlike some other anoctamins that function primarily as calcium-activated chloride channels, ANO4 exhibits unique properties:
- Calcium-activated chloride channel: ANO4 conducts chloride ions in response to intracellular calcium increases
- Phospholipid scramblase activity: Some anoctamin family members can flip phospholipids across the plasma membrane in a calcium-dependent manner
- Voltage dependence: Shows weak voltage dependence compared to other CaCCs
ANO4 demonstrates tissue-specific expression:
- Brain: High expression in hypothalamus, cortex, and hippocampus
- Endocrine tissues: Strong expression in pancreatic islets, adrenal gland
- Gastrointestinal tract: Moderate expression in stomach and intestines
ANO4 contributes to neuronal signaling through several mechanisms:
- Presynaptic modulation: Calcium-activated chloride currents can regulate neurotransmitter release by modulating presynaptic membrane potential
- Excitability control: Chloride channel activity influences neuronal resting membrane potential and excitability
- Volume regulation: ANO4 may participate in regulatory volume decrease (RVD) in neurons
- Astrocyte signaling: ANO4 expression in astrocytes suggests roles in glial-neuronal communication
- Ion homeostasis: Contributes to chloride homeostasis in the brain parenchyma
- Amyloid-β effects: Studies suggest altered ANO4 expression in response to amyloid-β pathology
- Calcium dysregulation: AD-related calcium dysregulation may affect ANO4 channel function
- Therapeutic potential: ANO4 modulators could potentially influence neuronal hyperexcitability in AD
- Dopaminergic neurons: ANO4 expression in substantia nigra suggests potential involvement in PD pathogenesis
- Calcium hypothesis: ANO4's calcium dependence links it to the "calcium hypothesis" of PD
- Neuroprotection: Targeting ANO4 may offer neuroprotective strategies
- Epilepsy: Altered CaCC function may contribute to epileptogenesis
- Neuropathic pain: ANO4 in sensory neurons may modulate pain signaling
ANO4 represents a potential drug target for:
- Neurological disorders: Modulators could treat neuronal hyperexcitability
- Endocrine disorders: ANO4 in pancreatic β-cells suggests roles in diabetes
- Cancer: Altered ANO4 expression in certain cancers
- Selectivity: Developing selective ANO4 modulators is challenging due to family homology
- Delivery: Targeting brain-specific ANO4 requires blood-brain barrier consideration
- Patch clamp: Whole-cell and inside-out configurations to measure CaCC currents
- Fluorescent chloride indicators: To visualize chloride flux
- CRISPR-Cas9: For generating ANO4 knockout models
- RNAi: siRNA-mediated knockdowns in cell culture
- Ano4 knockout mice: Generated to study physiological functions
- Transgenic models: To investigate disease-specific mutations
¶ Interactions and Pathways
- Calmodulin: ANO4 activity is modulated by calcium-calmodulin
- Other ion channels: May interact with GABA_A receptors and potassium channels
- Calcium signaling: Upstream regulators include IP3 receptors and voltage-gated calcium channels
- cAMP signaling: Cross-talk with cAMP-dependent pathways